Search results for:
enfortumab vedotin-ejfv
enfortumab vedotin-ejfv
| Drug Name |
Form |
Strength |
ARHS |
Blue Ridge |
Caldwell |
Chatham |
Johnston |
Lenoir |
Medical Center |
Nash |
Pardee |
Rex |
Rockingham |
Southeastern |
Wayne |
Youth Behavioral Health |
| Enfortumab Vedotin-ejfv |
POWDER FOR INJECTION, INTRAVENOUS |
30 mg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Last updated: Jul. 14, 2023
UNC Health
Caution– Category 1: Antineoplastic Hazardous Medication, see below for exposure mitigation strategies
System Formulary Restriction:
Use of enfortumab vedotin-ejfv injection (Padcev) is restricted to outpatient encounters or clinic use only (ie, no inpatient use)
Management of Chemotherapeutic or Hazardous Intravenous Extravasations Formulary Fact Sheet
Med Center
UNC Medical Center Formulary Restrictions